5 Questions with Kayla Valdes, Ph.D. Senior Manager, Horizon Therapeutics

Published on : Published by : BioBuzz Media

Dr. Kayla Valdes is a Senior Manager at Horizon Therapeutics, a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare diseases. Prior to joining Horizon, Dr. Valdes worked at the National Institutes of Health as a Senior Program Manager on the Cure Sickle Cell Initiative. She was also the Associate Director of Scientific Programs at the Drug Information Association (DIA), where she developed DIA’s global content strategy by providing scientific expertise in therapeutic drug development and regulatory policy.

BioHealth Capital Region Retains Strong Grip on No. 4 Spot of Top 10 U.S. Biopharma Hubs Eyes Third Spot by 2023

BioHealth Capital Region growth
Published on : Published by : Alex Keown

As a life sciences cluster, the BioHealth Capital Region is poised to become a top-three cluster in the Genetic Engineering & Biotechnology News (GEN) Top 10 Biopharma Clusters ranking on the strengths of early-stage companies becoming commercial successes and the construction of millions of square feet of new wet lab space.

BioHealth Innovation Adds Diane Ignar, Ph.D. and Dr. Loleta Robinson as NIH New Entrepreneurs-in-Residence

Published on : Published by : BioBuzz Media

BioHealth Innovation Inc. (BHI) announces the addition of Diane Ignar, Ph.D., and Dr. Loleta Robinson to the expanding Entrepreneurs-in-Residence (EIR) team. The Entrepreneur-in-Residence Program at BHI ensures that disruptive technologies receive all the resources required to transform the technology from a discovery into a commercially relevant product and eventually have a measurable impact on human health. The program was created to support scientists, early-stage startups, and licensed technologies to provide them with access to these resources. Diane will work with NIH’s National Institute on Aging, and Loleta will work with their Office of Extramural Research.

5 Questions with Stephanie M. Davis, Ph.D., Program Officer, National Heart, Lung, and Blood Institute

Published on : Published by : Andy Eckert

“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region and beyond to share a little about themselves, their work, and maybe something completely unrelated. This week we welcome Stephanie M. Davis, Ph.D., Program Officer, National Heart, Lung, and Blood Institute. Stay tuned for more interviews with others from across the BioHealth Capital Region and beyond.